Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Estrogens and brain function.

Athina Markou1, Theodora Duka, Gordana M Prelevic

  • 1Department of Endocrinology and Diabetes, G. Gennimatas Hospital, Athens, Greece.

Hormones (Athens, Greece)
|April 1, 2006
PubMed
Summary

Estrogen therapy may benefit cognitive function in postmenopausal women, but evidence is mixed, especially for those over 65. Estrogen

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre- and post-operative metabolic profile of patients with pheochromocytoma: A retrospective multicenter study.

Endocrine·2026
Same author

Five years of wastewater surveillance reveal COVID-19-Associated amplification and seasonal shifts in <i>bla</i> <sub>KPC</sub> and <i>bla</i> <sub>NDM</sub>.

One health (Amsterdam, Netherlands)·2026
Same author

Wastewater genomic surveillance of SARS-CoV-2 by nanopore sequencing uncovers JN.1 prevalence and novel spike mutational hotspots in Athens during winter 2024-2025.

The Science of the total environment·2026
Same author

Prognostic value of <i>MYD88</i>/<i>CXCR4</i> mutation allele fraction in Waldenström macroglobulinemia using a multiplex ddPCR assay.

HemaSphere·2026
Same author

Prognostic factors for cardiovascular complications induced by catecholamines in pheochromocytomas and paragangliomas: a systematic review and meta-analysis.

Hormones (Athens, Greece)·2026
Same author

ESR1 methylation and ESR1 mutations in circulating tumor cells (CTCs) and paired plasma-cfDNA of advanced breast cancer patients: A feasibility proof-of-concept study.

Molecular oncology·2026

Area of Science:

  • Neuroscience
  • Gerontology
  • Endocrinology

Background:

  • Cognitive decline accelerates in women post-menopause, with greater brain aging differences between sexes.
  • Estrogens show neuroprotective effects in vitro, but human mechanisms and benefits remain unclear.
  • Alzheimer's disease (AD) prevalence is significantly higher in women.

Purpose of the Study:

  • To review the role of estrogen in brain aging and cognitive function in women.
  • To evaluate the efficacy of estrogen therapy for cognitive health in postmenopausal women.
  • To assess estrogen's potential in Alzheimer's disease prophylaxis.

Main Methods:

  • Review of randomized trials and observational studies on estrogen therapy and cognition.
  • Analysis of data from large studies like the Women's Health Initiative Study (WHIMS).
  • Examination of estrogen's effects on the nervous system via estrogen receptors and other pathways.

Main Results:

  • Small trials suggest estrogen therapy may benefit cognition in symptomatic postmenopausal women.
  • The WHIMS study indicated no cognitive benefit, and potential harm, in women over 65.
  • Estrogen's role in Alzheimer's disease prophylaxis warrants further investigation.

Conclusions:

  • Current evidence supports short-term hormone replacement therapy (HRT) for menopausal symptoms.
  • Routine estrogen use for Alzheimer's disease is not currently justified.
  • Estrogen's complex effects on brain aging and cognition require further research, particularly regarding timing and specific populations.

Related Experiment Videos